300434 Sichuan Goldstone
- 7.70
- -0.08-1.03%
Sichuan Goldstone News
Sichuan Goldstone: 300434 Jinshi Asia Pharmaceutical Investor Relations Management Information 20240517
Sichuan Goldstone: 2023 Independent Director Debriefing Report (Liu Chuwang)
Sichuan Goldstone: Announcement on the proposed renewal of financial auditors and internal control auditors in 2024
Sichuan Goldstone: Announcement of Board Resolutions
Sichuan Goldstone: Announcement on holding the 2023 online results briefing
Sichuan Goldstone: 2023 Independent Director Debriefing Report (Zhu Jianwei)
Sichuan Goldstone: 2023 Independent Director Debriefing Report (Miao Jianquan)
Sichuan Goldstone: 2023 Independent Director Debriefing Report (Zhao Xiaowei)
Sichuan Goldstone: Assessment report on the recoverable value assets of the asset group portfolio involved in the proposed impairment test of goodwill formed by merging Hainan Asia Pharmaceutical Co., Ltd.
Sichuan Goldstone: 2023 Independent Director Debriefing Report (Zhong Peng)
Sichuan Goldstone: The Board's special opinion on the sole director's independence assessment
Sichuan Goldstone: Announcement of Supervisory Board Resolutions
Sichuan Goldstone: Asset group recyclable value asset assessment report involved in the proposed impairment test of goodwill formed by merging Zhejiang Jiande Zhengfa Pharmaceutical Co., Ltd.
Sichuan Goldstone: Internal Control Assurance Report
Sichuan Goldstone: 2023 Annual Audit Report
Sichuan Goldstone: 2023 Independent Director Debriefing Report (Ma Wenjie)
Sichuan Goldstone: Report on the work of the Board of Supervisors for the year 2023
Sichuan Goldstone: Notice on applying for loans from banks and other financial institutions
Sichuan Goldstone: 2023 Independent Director Debriefing Report (Jia Youlong)
Sichuan Goldstone: 2023 Independent Director Debriefing Report (Wang Lili)
Analysis
Price Target
No Data
